Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Chronische hepatitis B: wie kan stoppen met nucleos(t)ideanalogen?
jun 2022 | Hepatitis, Hepatologie, Virale infecties